| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.787 | 0.004 | 0.864 | Anticonvulsant | 0.767 0.004 CID_520217 0.864 0.004 CID_128908 | CID_128908 | |
| 0.652 | 0.003 | 0.691 | GABA A receptor antagonist | 0.638 0.003 CID_520217 0.691 0.003 CID_128908 | CID_128908 | |
| 0.639 | 0.003 | 0.681 | GABA receptor antagonist | 0.637 0.003 CID_520217 0.681 0.003 CID_128908 | CID_128908 | |
| 0.625 | 0.004 | 0.625 | Sigma receptor agonist | 0.51 0.009 CID_520217 0.136 0.096 CID_128908 | ||
| 0.594 | 0.008 | 0.594 | GABA C receptor rho-3 antagonist | 0.468 0.035 CID_520217 0.29 0.123 CID_128908 | ||
| 0.582 | 0.003 | 0.722 | GABA receptor agonist | 0.5 0.004 CID_520217 0.722 0.003 CID_128908 | CID_128908 | |
| 0.578 | 0.002 | 0.632 | Benzodiazepine agonist | 0.507 0.003 CID_520217 0.632 0.002 CID_128908 | CID_128908 | |
| 0.531 | 0.006 | 0.584 | Anesthetic general | 0.308 0.031 CID_520217 0.584 0.005 CID_128908 | CID_128908 | |
| 0.472 | 0.011 | 0.472 | Interleukin agonist | 0.352 0.028 CID_520217 0.243 0.084 CID_128908 | ||
| 0.322 | 0.02 | 0.322 | Gastrin inhibitor | 0.276 0.052 CID_520217 0.213 0.129 CID_128908 | ||
| 0.329 | 0.053 | 0.383 | Aryl hydrocarbon receptor agonist | 0.383 0.041 CID_520217 0.234 0.086 CID_128908 | CID_520217 | |
| 0.309 | 0.04 | 0.421 | Psychostimulant | 0.228 0.067 CID_520217 0.421 0.019 CID_128908 | CID_128908 | |
| 0.303 | 0.041 | 0.303 | Cyclic AMP phosphodiesterase inhibitor | 0.302 0.041 CID_520217 | ||
| 0.264 | 0.014 | 0.402 | Glutamate receptor antagonist | 0.402 0.005 CID_520217 | CID_520217 | |
| 0.23 | 0.007 | 0.23 | GABA A receptor agonist | 0.119 0.025 CID_520217 | ||
| 0.232 | 0.016 | 0.232 | GABA C receptor rho-2 antagonist | 0.183 0.04 CID_520217 | ||
| 0.203 | 0.01 | 0.233 | Glutamate (mGluR) antagonist | 0.233 0.008 CID_520217 | CID_520217 | |
| 0.2 | 0.009 | 0.362 | Potassium channel activator | 0.25 0.005 CID_520217 0.362 0.004 CID_128908 | CID_128908 | |
| 0.184 | 0.009 | 0.244 | Glutamate (mGluR group I) antagonist | 0.244 0.005 CID_520217 | CID_520217 | |
| 0.226 | 0.06 | 0.321 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.321 0.031 CID_520217 0.191 0.083 CID_128908 | CID_520217 | |
| 0.183 | 0.018 | 0.183 | Falcipain 2 inhibitor | 0.165 0.023 CID_520217 | ||
| 0.184 | 0.019 | 0.184 | Falcipain inhibitor | 0.166 0.024 CID_520217 | ||
| 0.167 | 0.004 | 0.167 | GABA B receptor antagonist | 0.128 0.004 CID_520217 0.045 0.026 CID_128908 | ||
| 0.203 | 0.04 | 0.203 | NOS3 expression enhancer | 0.18 0.05 CID_520217 0.15 0.072 CID_128908 | ||
| 0.181 | 0.019 | 0.181 | Interleukin 8 antagonist | 0.16 0.028 CID_520217 0.163 0.026 CID_128908 | ||
| 0.191 | 0.034 | 0.191 | Calcium channel blocker | 0.155 0.054 CID_520217 | ||
| 0.26 | 0.108 | 0.26 | Interleukin 2 agonist | |||
| 0.183 | 0.04 | 0.183 | Mannose-6-phosphate isomerase inhibitor | 0.177 0.044 CID_520217 0.158 0.058 CID_128908 | ||
| 0.191 | 0.05 | 0.191 | Polo-like kinase-3 inhibitor | 0.132 0.107 CID_520217 | ||
| 0.243 | 0.114 | 0.243 | Nootropic | |||
| 0.129 | 0.007 | 0.129 | Phosphodiesterase II inhibitor | 0.106 0.01 CID_520217 | ||
| 0.119 | 0.003 | 0.119 | Benzodiazepine antagonist | 0.081 0.005 CID_520217 0.059 0.014 CID_128908 | ||
| 0.312 | 0.197 | 0.429 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.429 0.077 CID_520217 | CID_520217 | |
| 0.12 | 0.006 | 0.12 | Phosphodiesterase 2A inhibitor | 0.097 0.009 CID_520217 | ||
| 0.195 | 0.085 | 0.267 | MAP kinase kinase 2 inhibitor | 0.267 0.047 CID_520217 | CID_520217 | |
| 0.163 | 0.055 | 0.163 | Toll-Like receptor 9 antagonist | |||
| 0.149 | 0.043 | 0.149 | DNA intercalator | 0.125 0.055 CID_520217 0.101 0.073 CID_128908 | ||
| 0.112 | 0.008 | 0.113 | Glutamate (mGluR5) antagonist | 0.113 0.008 CID_520217 | CID_520217 | |
| 0.138 | 0.037 | 0.177 | GABA C receptor antagonist | 0.177 0.019 CID_520217 | CID_520217 | |
| 0.107 | 0.007 | 0.107 | Potassium channel intermediate-conductance Ca-activated blocker | 0.09 0.012 CID_520217 | ||
| 0.129 | 0.033 | 0.129 | GABA C receptor rho-1 antagonist | 0.105 0.056 CID_520217 | ||
| 0.127 | 0.032 | 0.127 | Calcium antagonist | 0.084 0.06 CID_520217 | ||
| 0.102 | 0.008 | 0.202 | Cholecystokinin antagonist | 0.076 0.013 CID_520217 0.202 0.005 CID_128908 | CID_128908 | |
| 0.101 | 0.008 | 0.101 | Cholecystokinin A antagonist | 0.09 0.01 CID_520217 0.04 0.024 CID_128908 | ||
| 0.155 | 0.063 | 0.31 | Glycogen synthase kinase-3 alpha inhibitor | 0.31 0.015 CID_520217 | CID_520217 | |
| 0.192 | 0.103 | 0.301 | Nitric-oxide synthase stimulant | 0.301 0.011 CID_520217 | CID_520217 | |
| 0.088 | 0.005 | 0.286 | Purinergic P2X4 antagonist | 0.286 0.003 CID_520217 0.043 0.038 CID_128908 | CID_520217 | |
| 0.18 | 0.099 | 0.183 | Histone acetyltransferase inhibitor | 0.183 0.095 CID_520217 | CID_520217 | |
| 0.144 | 0.064 | 0.144 | Pregnane X receptor agonist | 0.135 0.085 CID_520217 | ||
| 0.092 | 0.016 | 0.092 | MAP kinase 7 inhibitor | 0.082 0.037 CID_128908 | ||
| 0.17 | 0.104 | 0.17 | Antimitotic | |||
| 0.084 | 0.022 | 0.084 | Androgen agonist | 0.079 0.025 CID_520217 0.064 0.036 CID_128908 | ||
| 0.118 | 0.059 | 0.118 | Calcium channel (voltage-sensitive) blocker | 0.115 0.063 CID_520217 | ||
| 0.081 | 0.023 | 0.081 | 5 Hydroxytryptamine 5A antagonist | 0.061 0.043 CID_520217 | ||
| 0.091 | 0.039 | 0.091 | Thioredoxin reductase inhibitor | 0.082 0.056 CID_520217 | ||
| 0.126 | 0.076 | 0.126 | NADPH oxidase inhibitor | |||
| 0.055 | 0.005 | 0.071 | Benzodiazepine receptor peripheral-type antagonist | 0.05 0.007 CID_520217 0.071 0.004 CID_128908 | CID_128908 | |
| 0.15 | 0.101 | 0.15 | ATPase inhibitor | 0.14 0.119 CID_520217 | ||
| 0.087 | 0.038 | 0.087 | Polo-like kinase-2 inhibitor | |||
| 0.101 | 0.055 | 0.116 | MAP kinase kinase 1 inhibitor | 0.108 0.047 CID_520217 0.116 0.039 CID_128908 | CID_128908 | |
| 0.078 | 0.032 | 0.078 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.06 | 0.015 | 0.073 | Benzodiazepine inverse agonist | 0.073 0.008 CID_520217 | CID_520217 | |
| 0.1 | 0.055 | 0.166 | Potassium channel (Ca-activated) activator | 0.166 0.023 CID_520217 | CID_520217 | |
| 0.066 | 0.022 | 0.111 | AMPA receptor antagonist | 0.111 0.01 CID_520217 | CID_520217 | |
| 0.118 | 0.076 | 0.118 | DNA repair enzyme inhibitor | 0.114 0.084 CID_520217 0.109 0.099 CID_128908 | ||
| 0.095 | 0.053 | 0.095 | Polo-like kinase-1 inhibitor | |||
| 0.068 | 0.027 | 0.068 | 5 Hydroxytryptamine 5 antagonist | 0.053 0.05 CID_520217 | ||
| 0.086 | 0.047 | 0.131 | Phosphodiesterase 3A inhibitor | 0.131 0.019 CID_520217 | CID_520217 | |
| 0.086 | 0.047 | 0.086 | Transforming growth factor beta 3 antagonist | 0.078 0.073 CID_520217 | ||
| 0.071 | 0.034 | 0.074 | Phosphodiesterase VII inhibitor | 0.074 0.031 CID_520217 | CID_520217 | |
| 0.22 | 0.184 | 0.352 | Calcium channel activator | 0.352 0.048 CID_520217 | CID_520217 | |
| 0.132 | 0.099 | 0.134 | Cyclin-dependent kinase 8 inhibitor | 0.134 0.098 CID_520217 | CID_520217 | |
| 0.183 | 0.151 | 0.183 | 5 Hydroxytryptamine 1E antagonist | 0.182 0.152 CID_520217 | ||
| 0.162 | 0.131 | 0.162 | Antiamyloidogenic | |||
| 0.062 | 0.031 | 0.062 | Bromodomain-containing protein 4 inhibitor | |||
| 0.089 | 0.06 | 0.128 | Pim-3 kinase inhibitor | 0.128 0.027 CID_520217 | CID_520217 | |
| 0.065 | 0.036 | 0.065 | Cyclin D1 inhibitor | 0.059 0.044 CID_520217 | ||
| 0.071 | 0.041 | 0.071 | Glutamate (mGluR7) antagonist | |||
| 0.128 | 0.1 | 0.128 | Thiol protease inhibitor | 0.127 0.103 CID_520217 | ||
| 0.083 | 0.059 | 0.086 | D-Ala-D-Ala ligase inhibitor | 0.086 0.054 CID_520217 0.086 0.053 CID_128908 | CID_128908 | |
| 0.061 | 0.038 | 0.149 | Glutamate (mGluR1) antagonist | 0.149 0.006 CID_520217 | CID_520217 | |
| 0.038 | 0.015 | 0.151 | Cholecystokinin B antagonist | 0.151 0.004 CID_128908 | CID_128908 | |
| 0.157 | 0.134 | 0.177 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.177 0.115 CID_520217 | CID_520217 | |
| 0.083 | 0.062 | 0.116 | Androgen antagonist | 0.116 0.035 CID_520217 | CID_520217 | |
| 0.107 | 0.087 | 0.129 | MAP kinase kinase inhibitor | 0.129 0.065 CID_520217 | CID_520217 | |
| 0.114 | 0.094 | 0.146 | Alkaline phosphatase inhibitor | 0.146 0.062 CID_520217 | CID_520217 | |
| 0.233 | 0.214 | 0.285 | MAP kinase kinase 6 inhibitor | 0.285 0.15 CID_520217 | CID_520217 | |
| 0.143 | 0.124 | 0.235 | Death-associated protein kinase 2 inhibitor | 0.235 0.017 CID_520217 0.147 0.114 CID_128908 | CID_520217 | |
| 0.086 | 0.069 | 0.091 | Alcohol dehydrogenase inhibitor | 0.091 0.063 CID_520217 0.09 0.065 CID_128908 | CID_520217 | |
| 0.163 | 0.147 | 0.199 | ErbB-1 antagonist | 0.199 0.09 CID_520217 | CID_520217 | |
| 0.097 | 0.083 | 0.097 | Multidrug resistance-associated protein 1 inhibitor | |||
| 0.105 | 0.092 | 0.105 | Transcription factor STAT6 inhibitor | |||
| 0.168 | 0.157 | 0.174 | RNA-directed DNA polymerase inhibitor | 0.174 0.144 CID_520217 | CID_520217 | |
| 0.141 | 0.132 | 0.141 | P-glycoprotein inhibitor | |||
| 0.02 | 0.012 | 0.02 | Progesterone receptor B antagonist | 0.019 0.013 CID_520217 0.019 0.015 CID_128908 | ||
| 0.064 | 0.059 | 0.082 | MDM2 inhibitor | 0.082 0.018 CID_520217 | CID_520217 | |
| 0.082 | 0.077 | 0.082 | Thioredoxin inhibitor | |||
| 0.084 | 0.08 | 0.084 | Creatine kinase inhibitor | |||
| 0.011 | 0.008 | 0.011 | CD80 antagonist | 0.011 0.008 CID_520217 | ||
| 0.16 | 0.158 | 0.198 | DNA damaging | 0.173 0.141 CID_520217 0.198 0.117 CID_128908 | CID_128908 | |
| 0.036 | 0.036 | 0.042 | Acid-sensing ion channel blocker | 0.042 0.026 CID_520217 | CID_520217 | |
| 0.125 | 0.127 | 0.191 | LIM domain kinase 1 inhibitor | 0.191 0.067 CID_520217 | CID_520217 | |
| 0.028 | 0.031 | 0.037 | Progesterone antagonist | 0.037 0.024 CID_520217 | CID_520217 | |
| 0.18 | 0.183 | 0.333 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.229 0.126 CID_520217 0.333 0.044 CID_128908 | CID_128908 | |
| 0.046 | 0.051 | 0.048 | Phosphodiesterase 7A inhibitor | 0.048 0.045 CID_520217 | CID_520217 | |
| 0.018 | 0.026 | 0.033 | Kainate receptor 4 antagonist | 0.033 0.012 CID_520217 | CID_520217 | |
| 0.089 | 0.099 | 0.126 | Protein kinase C gamma inhibitor | 0.126 0.048 CID_128908 | CID_128908 | |
| 0.246 | 0.259 | 0.299 | Caspase 9 stimulant | 0.267 0.233 CID_520217 0.299 0.195 CID_128908 | CID_128908 | |
| 0.077 | 0.093 | 0.105 | DNA directed RNA polymerase inhibitor | 0.105 0.051 CID_520217 | CID_520217 | |
| 0.162 | 0.181 | 0.195 | DNA synthesis inhibitor | 0.195 0.131 CID_128908 | CID_128908 | |
| 0.026 | 0.046 | 0.05 | Kinesin antagonist | 0.05 0.016 CID_520217 | CID_520217 | |
| 0.026 | 0.046 | 0.05 | Kinesin-like protein 1 inhibitor | 0.05 0.016 CID_520217 | CID_520217 | |
| 0.011 | 0.031 | 0.017 | Kainate receptor 3 antagonist | 0.017 0.012 CID_520217 | CID_520217 | |
| 0.023 | 0.049 | 0.03 | Catechol O-methyltransferase inhibitor | 0.03 0.027 CID_128908 | CID_128908 | |
| 0.014 | 0.044 | 0.025 | Cyclin E2 inhibitor | 0.025 0.024 CID_520217 | CID_520217 | |
| 0.019 | 0.051 | 0.059 | Kainate receptor 2 antagonist | 0.059 0.012 CID_520217 | CID_520217 | |
| 0.042 | 0.076 | 0.065 | Fatty acid synthase inhibitor | 0.065 0.03 CID_520217 | CID_520217 | |
| 0.109 | 0.147 | 0.153 | TRKC antagonist | 0.153 0.098 CID_520217 | CID_520217 | |
| 0.095 | 0.135 | 0.143 | Protein kinase (CK1) gamma 1 inhibitor | 0.143 0.075 CID_520217 | CID_520217 | |
| 0.072 | 0.114 | 0.155 | Polo-like kinase-4 inhibitor | 0.155 0.033 CID_520217 | CID_520217 | |
| 0.066 | 0.111 | 0.089 | Triose-phosphate isomerase inhibitor | 0.089 0.061 CID_520217 | CID_520217 | |
| 0.082 | 0.127 | 0.117 | MAP kinase 12 inhibitor | 0.117 0.074 CID_520217 | CID_520217 | |
| 0.049 | 0.096 | 0.069 | Potassium channel large-conductance Ca-activated activator | 0.069 0.045 CID_520217 | CID_520217 | |
| 0.016 | 0.064 | 0.024 | NMDA 2D receptor antagonist | 0.024 0.023 CID_520217 | CID_520217 | |
| 0.012 | 0.062 | 0.03 | AMPA 3 receptor antagonist | 0.03 0.021 CID_520217 | CID_520217 | |
| 0.024 | 0.077 | 0.114 | Phosphodiesterase 3B inhibitor | 0.114 0.009 CID_520217 | CID_520217 | |
| 0.091 | 0.146 | 0.114 | Cytidine deaminase inhibitor | 0.114 0.107 CID_128908 | CID_128908 | |
| 0.061 | 0.117 | 0.107 | Pim-1 kinase inhibitor | 0.107 0.051 CID_520217 | CID_520217 | |
| 0.037 | 0.093 | 0.065 | Sodium/calcium exchanger inhibitor | 0.065 0.015 CID_520217 | CID_520217 | |
| 0.044 | 0.102 | 0.063 | Protein kinase C beta inhibitor | 0.063 0.062 CID_128908 | CID_128908 | |
| 0.1 | 0.158 | 0.137 | Protein kinase (CK1) gamma 3 inhibitor | 0.137 0.105 CID_520217 | CID_520217 | |
| 0.006 | 0.066 | 0.033 | AMPA 1 receptor antagonist | 0.033 0.019 CID_520217 | CID_520217 | |
| 0.033 | 0.094 | 0.065 | Protein kinase C eta inhibitor | 0.065 0.031 CID_128908 | CID_128908 | |
| 0.024 | 0.086 | 0.048 | NMDA receptor subunit 3B antagonist | 0.048 0.026 CID_520217 | CID_520217 | |
| 0.113 | 0.178 | 0.171 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.171 0.095 CID_520217 | CID_520217 | |
| 0.063 | 0.13 | 0.1 | Platelet activating factor antagonist | 0.1 0.078 CID_520217 | CID_520217 | |
| 0.114 | 0.184 | 0.138 | 3C-like protease (Human coronavirus) inhibitor | 0.138 0.124 CID_520217 | CID_520217 | |
| 0.121 | 0.193 | 0.143 | Neurotensin receptor agonist | 0.143 0.12 CID_520217 | CID_520217 | |
| 0.009 | 0.081 | 0.029 | NMDA receptor glycine site antagonist | 0.029 0.013 CID_520217 | CID_520217 | |
| 0.067 | 0.142 | 0.099 | MAP kinase 13 inhibitor | 0.099 0.083 CID_520217 | CID_520217 | |
| 0.082 | 0.161 | 0.166 | Protein kinase C nu inhibitor | 0.166 0.062 CID_128908 | CID_128908 | |
| 0.034 | 0.117 | 0.068 | Prostaglandin-E synthase inhibitor | 0.068 0.051 CID_520217 | CID_520217 | |
| 0.05 | 0.133 | 0.084 | Glycine receptor antagonist | 0.084 0.05 CID_520217 | CID_520217 | |
| 0.074 | 0.161 | 0.11 | Cytokine production inhibitor | 0.11 0.099 CID_520217 | CID_520217 | |
| 0.072 | 0.159 | 0.099 | DOPA decarboxylase inhibitor | 0.099 0.078 CID_520217 | CID_520217 | |
| 0.109 | 0.198 | 0.144 | MAP kinase kinase 4 inhibitor | 0.144 0.075 CID_520217 | CID_520217 | |
| 0.109 | 0.199 | 0.183 | Platelet aggregation inhibitor | 0.183 0.095 CID_520217 | CID_520217 | |
| 0.075 | 0.166 | 0.125 | Protein kinase (CK1) gamma inhibitor | 0.125 0.085 CID_520217 | CID_520217 | |
| 0.064 | 0.157 | 0.092 | Nav1.1 sodium channel blocker | 0.092 0.077 CID_128908 | CID_128908 | |
| 0.03 | 0.125 | 0.104 | Phosphodiesterase III inhibitor | 0.104 0.021 CID_520217 | CID_520217 | |
| 0.035 | 0.136 | 0.07 | Cyclin B3 inhibitor | 0.07 0.045 CID_520217 0.067 0.049 CID_128908 | CID_520217 | |
| 0.052 | 0.158 | 0.093 | Glycogen synthase kinase-3 beta inhibitor | 0.093 0.088 CID_520217 | CID_520217 | |
| 0.085 | 0.192 | 0.146 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.146 0.098 CID_520217 | CID_520217 | |
| 0.052 | 0.162 | 0.096 | Glycogen synthase kinase-3 inhibitor | 0.096 0.084 CID_520217 | CID_520217 | |
| 0.062 | 0.173 | 0.111 | Protein kinase (CK1) gamma 2 inhibitor | 0.111 0.073 CID_520217 | CID_520217 | |
| 0.061 | 0.173 | 0.115 | Beta glucuronidase inhibitor | 0.115 0.051 CID_520217 0.093 0.082 CID_128908 | CID_520217 | |
| 0.057 | 0.172 | 0.115 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.115 0.087 CID_520217 | CID_520217 | |
| 0.019 | 0.135 | 0.074 | NMDA 2C receptor antagonist | 0.074 0.03 CID_520217 | CID_520217 | |
| 0.07 | 0.191 | 0.149 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.149 0.089 CID_128908 | CID_128908 | |
| 0.051 | 0.172 | 0.08 | GABA B receptor agonist | 0.08 0.041 CID_520217 | CID_520217 | |
| 0.093 | 0.219 | 0.16 | Interleukin 6 antagonist | 0.16 0.075 CID_128908 | CID_128908 | |
| 0.036 | 0.172 | 0.103 | NMDA receptor antagonist | 0.103 0.045 CID_520217 | CID_520217 | |
| 0.082 | 0.227 | 0.158 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.158 0.124 CID_520217 | CID_520217 | |
| 0.091 | 0.236 | 0.159 | Death-associated protein kinase 3 inhibitor | 0.159 0.11 CID_520217 | CID_520217 | |
| 0.093 | 0.246 | 0.142 | Death-associated protein kinase 1 inhibitor | 0.142 0.052 CID_520217 | CID_520217 | |
| 0.08 | 0.239 | 0.153 | Dyrk kinase inhibitor | 0.153 0.133 CID_520217 | CID_520217 | |
| 0.169 | 0.338 | 0.464 | Calcium channel L-type activator | 0.464 0.043 CID_520217 | CID_520217 | |
| 0.073 | 0.334 | 0.127 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.127 0.123 CID_520217 | CID_520217 | |
| 0.084 | 0.425 | 0.141 | Cyclin-dependent kinase 3 inhibitor | 0.141 0.12 CID_520217 | CID_520217 | |
| 0.032 | 0.407 | 0.092 | Nav1.4 sodium channel blocker | 0.092 0.09 CID_520217 | CID_520217 | |
| 0.002 | 0.956 | 0.032 | 1,3-Beta-glucan synthase inhibitor | 0.032 0.011 CID_128908 | CID_128908 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |